Effectiveness of Vitagnus on depression and menopausal signs in climactric wome
Phase 3
- Conditions
- Menopausal and other perimenopausal disorders.Menopausal and female climacteric states
- Registration Number
- IRCT2016041322991N4
- Lead Sponsor
- Vice Chancellor for research of Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
The patients who have been menopaused at least two years ago; Depression (the score more than 16 in Beck Depression Scale); The patient´s desire to participate in the study
Exclusion criteria: The history of elevated mood; Psychosis; Severe suicidal thoughts; The history of renal disorders; The history of hepatic disorders
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient´s depressive condition. Timepoint: 3th and 6th weeks after treatment. Method of measurement: Beck Depression Scale.;Menopausal signs. Timepoint: 3th and 6th weeks after treatment. Method of measurement: Menopausal Rating Scale (Kapperman Scale).
- Secondary Outcome Measures
Name Time Method Adverse drug reaction. Timepoint: 3rd and 6th weeks after treatment. Method of measurement: Interview.